Following an overview of targeted nanomedicine, chapters discuss nanoparticulate
drug delivery systems that have gained growing recognition, and opportunities and challenges posed by the relevant biology.
Well, we compared 12 weeks of a 600-mg daily dose of CoQ'10, from a leading softgel and a leading chewable form, to our nanoparticulate
Q-Kin in patients with Parkinson's disease.
The coatings nanoparticulate
penetrates the cell walls at the molecular level and chemically seals the cellulose chain.
IMCOR Pharmaceutical is a specialty pharmaceutical company developing and marketing a platform of innovative imaging products including its current ultrasound contrast agent and PH-50, an investigational iodinated, nanoparticulate
formulation under evaluation as a subcutaneous or intravenous agent for both cardiovascular imaging and lymphography
has reported results of several studies demonstrating the superiority of its innovative calcium phosphate nanoparticulate
(CAP) vaccine adjuvant and delivery system, BioVant (TM), compared to the only approved adjuvant, aluminum salts (alum).
A commentary by guest editor Paul Ho looks at modern innovations in nanoparticulate
delivery of combination chemotherapeutics.
materials; synthesis, characterization, and processing.
The award will support formulation development and in vivo proof-of-concept studies to evaluate the efficacy of TREM-1-specific SCHOOL peptides in either the free or nanoparticulate
solids can be produced by a variety of processes.
This proprietary blend incorporates an active silanol group and nanoparticulate
that provides chemical interaction and bonding that ensures topcoat adhesion.
of Texas at Austin) have organized the contributions into sections covering "intelligent therapeutics," which involves responsive devices and drug delivery systems that can detect and respond to biological undesirables and/or release drugs, proteins, or therapeutic agents; therapeutic micro- and nanodevices; nanostructured therapeutic materials; and nanoparticulate
systems in intelligent therapy, although there is often significant thematic overlap.
IN THIS ARTICLE, PAUL BREEN, EXECUTIVE VICE PRESIDENT AND HEAD OF ELAN DRUG TECHNOLOGIES, PROVIDES AN OVERVIEW OF NANOTECHNOLOGY IN DRUG DELIVERY, HIGHLIGHTING RECENT SUCCESSES THAT MOVES IT FROM THE REALMS OF FANTASY INTO REALITY, AND OUTLINES THE VARIOUS APPROACHES USED BY COMPANIES TO ACHIEVE NANOPARTICULATE